UCL spin-out Matrix Mill Ltd, a company specialising in applying artificial intelligence and machine vision research to solve industry problems, has been acquir [...]
Matr, the online teaching platform, has announced it has closed a £4.75 million Series A investment round led by the UCL Technology Fund and Downing Ventures, w [...]
London, 19 June 2018 – Freeline Therapeutics Ltd (“Freeline”), a clinical stage company focused on treatment of chronic systemic diseases with liver targeted ad [...]
UCL Spinout MeiraGTx Holdings plc a vertically integrated, clinical stage gene therapy company, announced the closing of its initial public offering of 5,000,00 [...]
On Thursday 3rd May, the UCL Technology Fund hosted a showcase event, in celebration of the first two years of the £50 million fund. Co-managed by UCLB a [...]
Global University venturing has awarded the 2018 Deal of the Year Award to UCLB spinout, Orchard Therapeutics; a biotechnology company dedicated to transforming [...]
The UCL Technology Fund (UCLTF), UK Innovation & Science Seed Fund (UKI2S), alongside support from Innovate UK, have invested in UCL spinout company [...]
Hazy (formerly Anon AI), one of our spin out companies, has won this year’s Microsoft Innovate AI competition. The award highlights start-ups harnessing the pow [...]
Today, the clinical-stage gene therapy company, announced its recent strategic agreement with GSK, to acquire its portfolio of approved and investigational rare [...]
UCL spinout company, Intrinsic, launched its new website today. Intrinsic was established to commercialise the novel memristive RRAM devices developed by Prof T [...]
